BioNTech SE Current Assets
BioNTech SE (BNTX) had Current Assets of EUR 16.15 billion as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:CurrentAssets · last filed 2026-03-10
- 2025-12-31: Current Assets 16.15B EUR.
- 2024-12-31: Current Assets 18.80B EUR.
- 2023-12-31: Current Assets 19.53B EUR.
- 2022-12-31: Current Assets 21.92B EUR.
| Period end | Current Assets | Current Assets as first filed |
|---|---|---|
| 2025-12-31 | 16.15B EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 18.80B EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 19.53B EUR 20-F · filed 2025-03-10 | |
| 2022-12-31 | 21.92B EUR 20-F · filed 2024-03-20 | |
| 2021-12-31 | 15.07B EUR 20-F · filed 2023-03-27 | |
| 2020-12-31 | 1.67B EUR 20-F/A · filed 2022-10-26 | 1.67B EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 560.15M EUR 20-F · filed 2021-03-30 | |
| 2018-12-31 | 448.96M EUR 20-F · filed 2020-03-31 |